Literature DB >> 18941188

OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.

Seyed Fazlollah Mousavi1, Pejman Soroosh, Takeshi Takahashi, Yasunobu Yoshikai, Hao Shen, Leo Lefrançois, Jannie Borst, Kazuo Sugamura, Naoto Ishii.   

Abstract

A T cell costimulatory molecule, OX40, contributes to T cell expansion, survival, and cytokine production. Although several roles for OX40 in CD8(+) T cell responses to tumors and viral infection have been shown, the precise function of these signals in the generation of memory CD8(+) T cells remains to be elucidated. To address this, we examined the generation and maintenance of memory CD8(+) T cells during infection with Listeria monocytogenes in the presence and absence of OX40 signaling. We used the expression of killer cell lectin-like receptor G1 (KLRG1), a recently reported marker, to distinguish between short-lived effector and memory precursor effector T cells (MPECs). Although OX40 was dispensable for the generation of effector T cells in general, the lack of OX40 signals significantly reduced the number and proportion of KLRG1(low) MPECs, and, subsequently, markedly impaired the generation of memory CD8(+) T cells. Moreover, memory T cells that were generated in the absence of OX40 signals in a host animal did not show self-renewal in a second host, suggesting that OX40 is important for the maintenance of memory T cells. Additional experiments making use of an inhibitory mAb against the OX40 ligand demonstrated that OX40 signals are essential during priming, not only for the survival of KLRG1(low) MPECs, but also for their self-renewing ability, both of which contribute to the homeostasis of memory CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941188      PMCID: PMC2784683          DOI: 10.4049/jimmunol.181.9.5990

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

Authors:  Kazuo Sugamura; Naoto Ishii; Andrew D Weinberg
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 2.  CD8 T cell memory.

Authors:  B Rocha; C Tanchot
Journal:  Semin Immunol       Date:  2004-10       Impact factor: 11.130

3.  A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Subash Sad; Hao Shen; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

4.  Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

Authors:  I Gramaglia; A D Weinberg; M Lemon; M Croft
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

5.  Cytotoxic T-cell memory without antigen.

Authors:  L L Lau; B D Jamieson; T Somasundaram; R Ahmed
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

Review 6.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

Review 7.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 8.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

9.  OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.

Authors:  Naoto Ishii; Lishomwa C Ndhlovu; Kazuko Murata; Takayuki Sato; Masahito Kamanaka; Kazuo Sugamura
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

10.  Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

Authors:  Ikuo Takeda; Shoji Ine; Nigel Killeen; Lishomwa C Ndhlovu; Kazuko Murata; Susumu Satomi; Kazuo Sugamura; Naoto Ishii
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

View more
  38 in total

Review 1.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  The persistence of T cell memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

Review 3.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

Review 4.  Science gone translational: the OX40 agonist story.

Authors:  Andrew D Weinberg; Nicholas P Morris; Magdalena Kovacsovics-Bankowski; Walter J Urba; Brendan D Curti
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

5.  PD-1 expression on CD8+ T cells regulates their differentiation within lung allografts and is critical for tolerance induction.

Authors:  T Takahashi; H M Hsiao; S Tanaka; W Li; R Higashikubo; D Scozzi; A Bharat; J H Ritter; A S Krupnick; A E Gelman; D Kreisel
Journal:  Am J Transplant       Date:  2017-08-23       Impact factor: 8.086

6.  A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.

Authors:  Yufeng Xie; Lu Wang; Andrew Freywald; Mabood Qureshi; Yue Chen; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2012-10-08       Impact factor: 11.530

7.  Interruption of OX40L signaling prevents costimulation blockade-resistant allograft rejection.

Authors:  William H Kitchens; Ying Dong; David V Mathews; Cynthia P Breeden; Elizabeth Strobert; Maria E Fuentes; Christian P Larsen; Mandy L Ford; Andrew B Adams
Journal:  JCI Insight       Date:  2017-03-09

Review 8.  Advances in the development of cancer immunotherapies.

Authors:  Jianjun Gao; Chantale Bernatchez; Padmanee Sharma; Laszlo G Radvanyi; Patrick Hwu
Journal:  Trends Immunol       Date:  2012-09-30       Impact factor: 16.687

9.  Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.

Authors:  Hong Jiang; Yisel Rivera-Molina; Candelaria Gomez-Manzano; Karen Clise-Dwyer; Laura Bover; Luis M Vence; Ying Yuan; Frederick F Lang; Carlo Toniatti; Mohammad B Hossain; Juan Fueyo
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

Review 10.  Diversity in CD8(+) T cell differentiation.

Authors:  Ian A Parish; Susan M Kaech
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.